Most Read Articles
4 days ago
Prenatal and postpartum vitamin D supplementation does not appear to improve foetal or infant growth, a study reports.
6 days ago
Excessive daytime sleepiness appears to increase the long-term risk of amyloid β (Aβ) deposition, a recent study has shown.
6 days ago
Substituting diets high in carbohydrates with those high in monounsaturated fatty acids in the context of low saturated fatty acids do not appear to yield favourable effects on blood pressure, according to a meta-analysis.
2 days ago
Patients with chronic kidney disease appear to be at greater risk of developing type 2 diabetes mellitus (T2DM) compared with the general population, with predictors including poor baseline glycaemic control and family history of diabetes mellitus, a study has found.

Psoriatic patients underdiagnosed, undertreated for hypertension and dyslipidaemia

08 Mar 2018

There appear to be several patients with psoriasis and psoriatic arthritis (PsA) who are underdiagnosed and undertreated for hypertension and dyslipidaemia in actual situations, a recent study has found.

Overall, 2,254 patients (58.9 percent PsA; 41.1 percent psoriasis; mean age 52 years; 53 percent men) from eight centres in Canada, Israel and the United States were included in this study.

Of the participants, 87.6 percent had at least one modifiable cardiovascular risk factor (CVRF), 45.1 percent had hypertension, 49.4 percent dyslipidaemia, 13.3 percent diabetes, 75.3 percent were overweight or obese, 54.3 percent had central obesity, and 17.3 percent were current smokers.

There were 59.2 percent and 65.6 percent of patients with hypertension and dyslipidaemia, respectively, who were undertreated. Moreover, undertreatment correlated with younger age (≤50 years), having psoriasis and male sex.

To estimate the number of underdiagnosis and undertreatment of CVRF in an international multicentre cohort of patients with psoriasis and PsA, researchers conducted a cross-sectional of patients with psoriatic disease form the International Psoriasis and Arthritis Research Team cohort. They determined the presence of modifiable CVRF (diabetes, hypertension, dyslipidaemia, smoking, elevated body mass index and central obesity) and the use of appropriate therapies for hypertension and dyslipidaemia.

The Framingham Risk Score was used to calculate the 10-year CV risk. Physician adherence with guidelines for the treatment of hypertension and dyslipidaemia was also evaluated. Finally, researchers used regression analysis to assess predictors of undertreatment of hypertension and dyslipidaemia.

“Strategies to improve the management of CVRF in psoriatic patients are warranted,” according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Prenatal and postpartum vitamin D supplementation does not appear to improve foetal or infant growth, a study reports.
6 days ago
Excessive daytime sleepiness appears to increase the long-term risk of amyloid β (Aβ) deposition, a recent study has shown.
6 days ago
Substituting diets high in carbohydrates with those high in monounsaturated fatty acids in the context of low saturated fatty acids do not appear to yield favourable effects on blood pressure, according to a meta-analysis.
2 days ago
Patients with chronic kidney disease appear to be at greater risk of developing type 2 diabetes mellitus (T2DM) compared with the general population, with predictors including poor baseline glycaemic control and family history of diabetes mellitus, a study has found.